MoonLake Immunotherapeutics (MLTX)
46.76
+0.34
(+0.73%)
USD |
NASDAQ |
Nov 01, 16:00
46.48
-0.28
(-0.60%)
After-Hours: 20:00
MoonLake Immunotherapeutics Market Cap: 2.941B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.941B |
| October 31, 2024 | 2.919B |
| October 30, 2024 | 2.956B |
| October 29, 2024 | 3.031B |
| October 28, 2024 | 3.022B |
| October 25, 2024 | 2.937B |
| October 24, 2024 | 2.905B |
| October 23, 2024 | 2.930B |
| October 22, 2024 | 3.019B |
| October 21, 2024 | 3.083B |
| October 18, 2024 | 3.078B |
| October 17, 2024 | 3.024B |
| October 16, 2024 | 3.089B |
| October 15, 2024 | 3.019B |
| October 14, 2024 | 3.075B |
| October 11, 2024 | 3.078B |
| October 10, 2024 | 2.956B |
| October 09, 2024 | 2.999B |
| October 08, 2024 | 3.135B |
| October 07, 2024 | 3.254B |
| October 04, 2024 | 3.476B |
| October 03, 2024 | 3.270B |
| October 02, 2024 | 3.259B |
| October 01, 2024 | 3.253B |
| September 30, 2024 | 3.171B |
| Date | Value |
|---|---|
| September 27, 2024 | 3.107B |
| September 26, 2024 | 3.231B |
| September 25, 2024 | 3.195B |
| September 24, 2024 | 3.412B |
| September 23, 2024 | 3.484B |
| September 20, 2024 | 3.398B |
| September 19, 2024 | 3.378B |
| September 18, 2024 | 3.340B |
| September 17, 2024 | 3.207B |
| September 16, 2024 | 3.143B |
| September 13, 2024 | 3.216B |
| September 12, 2024 | 3.210B |
| September 11, 2024 | 2.919B |
| September 10, 2024 | 2.931B |
| September 09, 2024 | 2.941B |
| September 06, 2024 | 2.894B |
| September 05, 2024 | 2.866B |
| September 04, 2024 | 2.982B |
| September 03, 2024 | 2.912B |
| August 30, 2024 | 2.943B |
| August 29, 2024 | 2.986B |
| August 28, 2024 | 2.944B |
| August 27, 2024 | 2.951B |
| August 26, 2024 | 3.029B |
| August 23, 2024 | 3.130B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
173.18M
Minimum
May 16 2022
3.861B
Maximum
Feb 12 2024
1.805B
Average
2.498B
Median
Market Cap Benchmarks
| Novartis AG | 218.62B |
| AC Immune SA | 296.82M |
| CRISPR Therapeutics AG | 4.323B |
| Addex Therapeutics Ltd | 11.44M |
| NLS Pharmaceutics Ltd | 13.73M |
Market Cap Related Metrics
| Price to Book Value | 5.648 |
| Price | 46.76 |
| Earnings Yield | -1.90% |